PRME
Price
$1.66
Change
-$0.03 (-1.78%)
Updated
Apr 28, 04:56 PM (EDT)
Capitalization
221.66M
11 days until earnings call
RXRX
Price
$5.83
Change
+$0.11 (+1.92%)
Updated
Apr 28, 04:59 PM (EDT)
Capitalization
2.3B
9 days until earnings call
Ad is loading...

PRME vs RXRX

Header iconPRME vs RXRX Comparison
Open Charts PRME vs RXRXBanner chart's image
Prime Medicine
Price$1.66
Change-$0.03 (-1.78%)
Volume$4.29K
Capitalization221.66M
Recursion Pharmaceuticals
Price$5.83
Change+$0.11 (+1.92%)
Volume$127.77K
Capitalization2.3B
PRME vs RXRX Comparison Chart
Loading...
PRME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PRME vs. RXRX commentary
Apr 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRME is a Hold and RXRX is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 28, 2025
Stock price -- (PRME: $1.69 vs. RXRX: $5.73)
Brand notoriety: PRME and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PRME: 69% vs. RXRX: 55%
Market capitalization -- PRME: $221.66M vs. RXRX: $2.3B
PRME [@Biotechnology] is valued at $221.66M. RXRX’s [@Biotechnology] market capitalization is $2.3B. The market cap for tickers in the [@Biotechnology] industry ranges from $272.78B to $0. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PRME’s FA Score shows that 0 FA rating(s) are green whileRXRX’s FA Score has 0 green FA rating(s).

  • PRME’s FA Score: 0 green, 5 red.
  • RXRX’s FA Score: 0 green, 5 red.
According to our system of comparison, both PRME and RXRX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PRME’s TA Score shows that 6 TA indicator(s) are bullish while RXRX’s TA Score has 4 bullish TA indicator(s).

  • PRME’s TA Score: 6 bullish, 2 bearish.
  • RXRX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, PRME is a better buy in the short-term than RXRX.

Price Growth

PRME (@Biotechnology) experienced а +36.29% price change this week, while RXRX (@Biotechnology) price change was +4.18% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.03%. For the same industry, the average monthly price growth was +0.98%, and the average quarterly price growth was -8.84%.

Reported Earning Dates

PRME is expected to report earnings on May 09, 2025.

RXRX is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+11.03% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($2.3B) has a higher market cap than PRME($222M). RXRX YTD gains are higher at: -15.237 vs. PRME (-42.123). PRME has higher annual earnings (EBITDA): -196.34M vs. RXRX (-426.72M). RXRX has more cash in the bank: 594M vs. PRME (190M). PRME has less debt than RXRX: PRME (40.8M) vs RXRX (108M). RXRX has higher revenues than PRME: RXRX (58.5M) vs PRME (2.98M).
PRMERXRXPRME / RXRX
Capitalization222M2.3B10%
EBITDA-196.34M-426.72M46%
Gain YTD-42.123-15.237276%
P/E RatioN/AN/A-
Revenue2.98M58.5M5%
Total Cash190M594M32%
Total Debt40.8M108M38%
FUNDAMENTALS RATINGS
PRME: Fundamental Ratings
PRME
OUTLOOK RATING
1..100
19
VALUATION
overvalued / fair valued / undervalued
1..100
44
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
95
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
58

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PRMERXRX
RSI
ODDS (%)
Bullish Trend 7 days ago
90%
Bullish Trend 7 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 7 days ago
81%
Bearish Trend 7 days ago
89%
Momentum
ODDS (%)
Bullish Trend 7 days ago
84%
Bullish Trend 7 days ago
86%
MACD
ODDS (%)
Bullish Trend 7 days ago
87%
Bullish Trend 7 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 7 days ago
81%
Bullish Trend 7 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 7 days ago
88%
Bearish Trend 7 days ago
87%
Advances
ODDS (%)
Bullish Trend 7 days ago
78%
N/A
Declines
ODDS (%)
Bearish Trend 13 days ago
89%
Bearish Trend 21 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
85%
Bullish Trend 7 days ago
90%
Aroon
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 7 days ago
87%
View a ticker or compare two or three
Ad is loading...
PRME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA284.9525.44
+9.80%
Tesla
GME27.460.38
+1.40%
GameStop Corp
SPY550.643.95
+0.72%
SPDR® S&P 500® ETF
AAPL209.280.91
+0.44%
Apple
BTC.X93754.840000-892.085940
-0.94%
Bitcoin cryptocurrency

PRME and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRME has been loosely correlated with CRSP. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if PRME jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRME
1D Price
Change %
PRME100%
-3.43%
CRSP - PRME
62%
Loosely correlated
-2.15%
RXRX - PRME
58%
Loosely correlated
-0.35%
BEAM - PRME
56%
Loosely correlated
-3.22%
NTLA - PRME
56%
Loosely correlated
+1.59%
ABCL - PRME
52%
Loosely correlated
-1.15%
More